The Effects of IL-20 Subfamily Cytokines on Reconstituted Human Epidermis Suggest Potential Roles in Cutaneous Innate Defense and Pathogenic Adaptive Immunity in Psoriasis

IL-19, IL-20, IL-22, IL-24, and IL-26 are members of the IL-10 family of cytokines that have been shown to be up-regulated in psoriatic skin. Contrary to IL-10, these cytokines signal using receptor complex R1 subunits that are preferentially expressed on cells of epithelial origin; thus, we henceforth refer to them as the IL-20 subfamily cytokines. In this study, we show that primary human keratinocytes (KCs) express receptors for these cytokines and that IL-19, IL-20, IL-22, and IL-24 induce acanthosis in reconstituted human epidermis (RHE) in a dose-dependent manner. These cytokines also induce expression of the psoriasis-associated protein S100A7 and keratin 16 in RHE and cause persistent activation of Stat3 with nuclear localization. IL-22 had the most pronounced effects on KC proliferation and on the differentiation of KCs in RHE, inducing a decrease in the granular cell layer (hypogranulosis). Furthermore, gene expression analysis performed on cultured RHE treated with these cytokines showed that IL-19, IL-20, IL-22, and IL-24 regulate many of these same genes to variable degrees, inducing a gene expression profile consistent with inflammatory responses, wound healing re-epithelialization, and altered differentiation. Many of these genes have also been found to be up-regulated in psoriatic skin, including several chemokines, β-defensins, S100 family proteins, and kallikreins. These results confirm that IL-20 subfamily cytokines are important regulators of epidermal KC biology with potentially pivotal roles in the immunopathology of psoriasis.

[1]  B. Nickoloff,et al.  The cytokine network in psoriasis. , 1991, Archives of dermatology.

[2]  M. Yamamura,et al.  The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response. , 1993, The Journal of investigative dermatology.

[3]  O. Mcbride,et al.  Human trichohyalin gene is clustered with the genes for other epidermal structural proteins and calcium-binding proteins at chromosomal locus 1q21. , 1993, The Journal of investigative dermatology.

[4]  J. Darnell,et al.  Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. , 1994, Science.

[5]  W. Jochum,et al.  T cells involved in psoriasis vulgaris belong to the Th1 subset. , 1994, The Journal of investigative dermatology.

[6]  M. Manabe,et al.  Existence of trichohyalin-keratohyalin hybrid granules: co-localization of two major intermediate filament-associated proteins in non-follicular epithelia. , 1994, Differentiation; research in biological diversity.

[7]  Z. Su,et al.  Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression. , 1995, Oncogene.

[8]  B. Honoré,et al.  Psoriasin: a novel chemotactic protein. , 1996, The Journal of investigative dermatology.

[9]  M. Piepkorn,et al.  Overexpression of amphiregulin, a major autocrine growth factor for cultured human keratinocytes, in hyperproliferative skin diseases. , 1996, The American Journal of dermatopathology.

[10]  J. Darnell STATs and gene regulation. , 1997, Science.

[11]  Y. Hashimoto,et al.  Distinctive expression of filaggrin and trichohyalin during various pathways of epithelial differentiation , 1997, The British journal of dermatology.

[12]  J. Brown,et al.  Transgenic expression of the human amphiregulin gene induces a psoriasis-like phenotype. , 1997, The Journal of clinical investigation.

[13]  M. Pittelkow,et al.  Autocrine regulation of keratinocytes: the emerging role of heparin-binding, epidermal growth factor-related growth factors. , 1998, The Journal of investigative dermatology.

[14]  M. Longaker,et al.  Cutaneous rat wounds express C49a, a novel gene with homology to the human melanoma differentiation associated gene, Mda‐7 , 1999, Journal of cellular biochemistry.

[15]  M. Pittelkow,et al.  Overexpression of amphiregulin in the epidermis of transgenic mice induces a psoriasis-like cutaneous phenotype. , 1999, The Journal of investigative dermatology.

[16]  T. Kupper,et al.  Interleukin-1 and cutaneous inflammation: a crucial link between innate and acquired immunity. , 2000, The Journal of investigative dermatology.

[17]  Zemin Zhang,et al.  Interleukin (IL)-22, a Novel Human Cytokine That Signals through the Interferon Receptor-related Proteins CRF2–4 and IL-22R* , 2000, The Journal of Biological Chemistry.

[18]  A. Gurney,et al.  Acinar cells of the pancreas are a target of interleukin-22. , 2001, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[19]  A. Bowcock,et al.  Insights into psoriasis and other inflammatory diseases from large-scale gene expression studies. , 2001, Human molecular genetics.

[20]  D. Lejeune,et al.  Cutting Edge: STAT Activation By IL-19, IL-20 and mda-7 Through IL-20 Receptor Complexes of Two Types1 , 2001, The Journal of Immunology.

[21]  J G Krueger,et al.  Molecular classification of psoriasis disease-associated genes through pharmacogenomic expression profiling , 2001, The Pharmacogenomics Journal.

[22]  D. Conklin,et al.  Interleukin 20 Discovery, Receptor Identification, and Role in Epidermal Function , 2001, Cell.

[23]  S. Pestka,et al.  Identification of the Functional Interleukin-22 (IL-22) Receptor Complex , 2001, The Journal of Biological Chemistry.

[24]  A. Sahin,et al.  Down‐regulated melanoma differentiation associated gene (mda‐7) expression in human melanomas , 2001, International journal of cancer.

[25]  A D Long,et al.  Improved Statistical Inference from DNA Microarray Data Using Analysis of Variance and A Bayesian Statistical Framework , 2001, The Journal of Biological Chemistry.

[26]  K. Madden,et al.  Interleukins 19, 20, and 24 Signal through Two Distinct Receptor Complexes , 2002, The Journal of Biological Chemistry.

[27]  S. Kotenko,et al.  Interleukin 24 (MDA-7/MOB-5) Signals through Two Heterodimeric Receptors, IL-22R1/IL-20R2 and IL-20R1/IL-20R2* , 2002, The Journal of Biological Chemistry.

[28]  S. Kotenko,et al.  Interleukin 24 ( MDA-7 / MOB-5 ) Signals through Two Heterodimeric Receptors , IL-22 R 1 / IL-20 R 2 and IL-20 R 1 / IL-20 R 2 * , 2002 .

[29]  K. Asadullah,et al.  Cutting Edge: Immune Cells as Sources and Targets of the IL-10 Family Members? , 2002, The Journal of Immunology.

[30]  Selective enhancement of multipotential hematopoietic progenitors in vitro and in vivo by IL-20. , 2003, Blood.

[31]  J. Renauld Class II cytokine receptors and their ligands: Key antiviral and inflammatory modulators , 2003, Nature Reviews Immunology.

[32]  K. Kragballe,et al.  Epidermal overexpression of interleukin-19 and -20 mRNA in psoriatic skin disappears after short-term treatment with cyclosporine a or calcipotriol. , 2003, The Journal of investigative dermatology.

[33]  K. Kristiansen,et al.  Expression and localization of peroxisome proliferator-activated receptors and nuclear factor kappaB in normal and lesional psoriatic skin. , 2003, The Journal of investigative dermatology.

[34]  M. Blumenberg,et al.  Unique Keratinocyte-Specific Effects of Interferon-γ that Protect Skin from Viruses, Identified Using Transcriptional Profiling , 2002, Antiviral therapy.

[35]  John D. Storey,et al.  Statistical significance for genomewide studies , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[36]  R. Underwood,et al.  Proliferation–differentiation relationships in the expression of heparin-binding epidermal growth factor-related factors and erbB receptors by normal and psoriatic human keratinocytes , 2003, Archives of Dermatological Research.

[37]  Wing Hung Wong,et al.  Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucleotide array. , 2003, Physiological genomics.

[38]  T. Kupper,et al.  Immune surveillance in the skin: mechanisms and clinical consequences , 2004, Nature Reviews Immunology.

[39]  A. Zdanov Structural features of the interleukin-10 family of cytokines. , 2004, Current pharmaceutical design.

[40]  Kathleen C. Lee,et al.  S100 proteins in the epidermis. , 2004, The Journal of investigative dermatology.

[41]  F. Nestle,et al.  Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities. , 2004, The Journal of clinical investigation.

[42]  M. Pittelkow,et al.  Suprabasal expression of human amphiregulin in the epidermis of transgenic mice induces a severe, early‐onset, psoriasis‐like skin pathology: Expression of amphiregulin in the basal epidermis is also associated with synovitis , 2004, Experimental dermatology.

[43]  A. Gottlieb,et al.  A phase I study evaluating the safety, pharmacokinetics, and clinical response of a human IL-12 p40 antibody in subjects with plaque psoriasis. , 2004, The Journal of investigative dermatology.

[44]  M. Dhodapkar,et al.  Increased Expression of Interleukin 23 p19 and p40 in Lesional Skin of Patients with Psoriasis Vulgaris , 2004, The Journal of experimental medicine.

[45]  G. Church,et al.  Preferred analysis methods for Affymetrix GeneChips revealed by a wholly defined control dataset , 2005, Genome Biology.

[46]  T. Mcclanahan,et al.  Expression patterns of IL-10 ligand and receptor gene families provide leads for biological characterization. , 2004, International immunopharmacology.

[47]  M. Simon,et al.  Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/hK7. , 2004, The Journal of investigative dermatology.

[48]  K. Asadullah,et al.  IL-22 increases the innate immunity of tissues. , 2004, Immunity.

[49]  S. Kotenko,et al.  Full house: 12 receptors for 27 cytokines. , 2004, International immunopharmacology.

[50]  S. Smirnov,et al.  Cutting Edge: IL-26 Signals through a Novel Receptor Complex Composed of IL-20 Receptor 1 and IL-10 Receptor 2 1 , 2004, The Journal of Immunology.

[51]  J. Renauld,et al.  The T-cell Lymphokine Interleukin-26 Targets Epithelial Cells through the Interleukin-20 Receptor 1 and Interleukin-10 Receptor 2 Chains* , 2004, Journal of Biological Chemistry.

[52]  A. Bowcock,et al.  Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and "Type 1" inflammatory gene expression. , 2004, Trends in immunology.

[53]  M. Blumenberg,et al.  Effects of Tumor Necrosis Factor-α (TNFα) in Epidermal Keratinocytes Revealed Using Global Transcriptional Profiling* , 2004, Journal of Biological Chemistry.

[54]  C. D. Krause,et al.  Interleukin-10 and related cytokines and receptors. , 2004, Annual review of immunology.

[55]  E. Diamandis,et al.  Multiple tissue kallikrein mRNA and protein expression in normal skin and skin diseases , 2005, The British journal of dermatology.

[56]  K. Hiromura,et al.  Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine. , 2005, Arthritis and rheumatism.

[57]  J. Schröder,et al.  Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection , 2005, Nature Immunology.

[58]  R. Pfundt,et al.  High expression levels of keratinocyte antimicrobial proteins in psoriasis compared with atopic dermatitis. , 2005, The Journal of investigative dermatology.

[59]  A. Bowcock,et al.  Getting under the skin: the immunogenetics of psoriasis , 2005, Nature Reviews Immunology.

[60]  James Varani,et al.  Amphiregulin and epidermal hyperplasia: amphiregulin is required to maintain the psoriatic phenotype of human skin grafts on severe combined immunodeficient mice. , 2005, The American journal of pathology.

[61]  A. Gurney,et al.  IL-22 Inhibits Epidermal Differentiation and Induces Proinflammatory Gene Expression and Migration of Human Keratinocytes1 , 2005, The Journal of Immunology.

[62]  A. Takayanagi,et al.  Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts. , 2005, Gastroenterology.

[63]  J. Clausen,et al.  The dynamics of gene expression of interleukin‐19 and interleukin‐20 and their receptors in psoriasis , 2005, The British journal of dermatology.

[64]  W‐C. Chen,et al.  Interleukin‐19 upregulates keratinocyte growth factor and is associated with psoriasis , 2005, The British journal of dermatology.

[65]  M. Boniotto,et al.  Human IL‐19 regulates immunity through auto‐induction of IL‐19 and production of IL‐10 , 2005, European journal of immunology.

[66]  J. Clifford,et al.  Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model , 2005, Nature Medicine.

[67]  M. Brattsand,et al.  A proteolytic cascade of kallikreins in the stratum corneum. , 2005, The Journal of investigative dermatology.

[68]  Ming-Shi Chang,et al.  Detection of IL-20 and its receptors on psoriatic skin. , 2005, Clinical immunology.

[69]  K. Herrmann,et al.  IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[70]  J. Krueger,et al.  Prominent production of IL-20 by CD68+/CD11c+ myeloid-derived cells in psoriasis: Gene regulation and cellular effects. , 2006, The Journal of investigative dermatology.

[71]  K. Asadullah,et al.  IL‐22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis , 2006, European journal of immunology.

[72]  Y. Iwakura,et al.  The IL-23/IL-17 axis in inflammation. , 2006, The Journal of clinical investigation.

[73]  P. Valdez,et al.  Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis , 2007, Nature.

[74]  D. Greenhalgh,et al.  Cutaneous Wound Healing , 2007, Journal of burn care & research : official publication of the American Burn Association.